As described in the National Cancer Institute's Policies and Guidelines Relating to the Cancer Center Support Grant, the Chao Family Comprehensive Cancer Center (CFCCC) seeks to promote excellent research among Cancer Center Members, turn research results into treatment or preventive therapies, prove that these work in the clinical setting, educate healthcare professionals about the latest advances, and reach out to under-served populations. To oversee this complex process, the CFCCC has established a Senior Leadership that provides overall direction and coordination among Cancer Center Members, staff, and the University of California, Irvine. Senior Leadership consists of the Director, Dr. Frank L. Meyskens, Jr., M.D., Deputy Director of Clinical Affairs, Dr. John Butler, M.D., CCSG Administrator, Ms. Jacqueline Hamilton, and four Associate Directors: Basic Sciences, Dr. Hung Fan, Ph.D.; Clinical Research, Dr. Randall Holcombe, M.D.; Cancer Control & Population Sciences, Dr. Hoda Anton-Culver, Ph.D.; Education & Training, Dr. J. Leslie Redpath, Ph.D. The Senior Leadership provides the impetus behind long-term planning, budgetary decisions, inter- and intra-programmatic research efforts, outreach and educational programs, recruitment efforts, and mentoring of fellows and junior faculty.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA062203-17S1
Application #
8567167
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-09-11
Project End
2014-01-31
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
17
Fiscal Year
2012
Total Cost
$74,994
Indirect Cost
$26,165
Name
University of California Irvine
Department
Type
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Carpenter, Philip M; Ziogas, Argyrios; Markham, Emma M et al. (2018) Laminin 332 expression and prognosis in breast cancer. Hum Pathol 82:289-296
Yan, Huaming; Romero-López, Mónica; Benitez, Lesly I et al. (2018) Multiscale modeling of glioblastoma. Transl Cancer Res 7:S96-S98
Yu, James; Landberg, Jenny; Shavarebi, Farbod et al. (2018) Bioengineering triacetic acid lactone production in Yarrowia lipolytica for pogostone synthesis. Biotechnol Bioeng 115:2383-2388
Oliver, Andrew; Kay, Matthew; Cooper, Kerry K (2018) Comparative genomics of cocci-shaped Sporosarcina strains with diverse spatial isolation. BMC Genomics 19:310
Mahlbacher, Grace; Curtis, Louis T; Lowengrub, John et al. (2018) Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment. J Immunother Cancer 6:10
Neek, Medea; Tucker, Jo Anne; Kim, Tae Il et al. (2018) Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses. Biomaterials 156:194-203
McLelland, Bryce T; Lin, Bin; Mathur, Anuradha et al. (2018) Transplanted hESC-Derived Retina Organoid Sheets Differentiate, Integrate, and Improve Visual Function in Retinal Degenerate Rats. Invest Ophthalmol Vis Sci 59:2586-2603
Bota, Daniela A; Chung, Jinah; Dandekar, Manisha et al. (2018) Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts. CNS Oncol 7:CNS22
Han, Han; Qi, Ruxi; Zhou, Jeff Jiajing et al. (2018) Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction. Mol Cell 72:328-340.e8
Solares, Edwin A; Chakraborty, Mahul; Miller, Danny E et al. (2018) Rapid Low-Cost Assembly of the Drosophila melanogaster Reference Genome Using Low-Coverage, Long-Read Sequencing. G3 (Bethesda) 8:3143-3154

Showing the most recent 10 out of 1106 publications